Announcements Trials
Browse Landscape

Status

Terminated 3Withdrawn 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Lenalidomide 4Rituximab 3zanubrutinib 2tafasitamab 2fludarabine 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2vorasidenib 1tislelizumab 1resiniferatoxin 1relmacabtagene autoleucel 1pomalidomide 1orelabrutinib 1obinutuzumab 1loncastuximab tesirine 1duvelisib 1Transurethral Resection of Bladder 1Temozolomide 1Standard of Care 1Spinal Puncture 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Prednisone 1Oxygen Consumption 1Interleukin-2 1Inhalation 1Furosemide 1Eflornithine 1Diet 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, Follicular × duvelisib × Clear all
NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

Ruijin Hospital

Not yet recruiting
200 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡